ArticleProjected 2023 Cost Reduction From Tumor Necrosis Factor α Inhibitor Biosimilars in Dermatology: A National Medicare AnalysisAuthor:Hao Feng, MD, MHSPublish date: October 21, 2024To the Editor:Although biologics provide major therapeutic benefits for dermatologic conditions, they also come with a substantial cost, ma...Read More
ArticleConcordance Between Dermatologist Self-reported and Industry-Reported Interactions at a National Dermatology ConferenceAuthor:Hao Feng, MD, MHSPublish date: April 7, 2020Physician-industry interactions are prevalent. Accurate reporting allows for transparency regarding potential conflicts of interest. This study&nbs...Read More
